189 related articles for article (PubMed ID: 12192466)
1. Intravenous antidepressant treatment: focus on citalopram.
Kasper S; Müller-Spahn F
Eur Arch Psychiatry Clin Neurosci; 2002 Jun; 252(3):105-9. PubMed ID: 12192466
[TBL] [Abstract][Full Text] [Related]
2. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
Lenox-Smith AJ; Jiang Q
Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of intravenous citalopram compared with oral citalopram for severe depression. Safety and efficacy data from a double-blind, double-dummy trial.
Guelfi JD; Strub N; Loft H
J Affect Disord; 2000 Jun; 58(3):201-9. PubMed ID: 10802128
[TBL] [Abstract][Full Text] [Related]
4. Citalopram intravenous infusion in resistant obsessive-compulsive disorder: an open trial.
Pallanti S; Quercioli L; Koran LM
J Clin Psychiatry; 2002 Sep; 63(9):796-801. PubMed ID: 12363120
[TBL] [Abstract][Full Text] [Related]
5. Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care.
Lepola UM; Loft H; Reines EH
Int Clin Psychopharmacol; 2003 Jul; 18(4):211-7. PubMed ID: 12817155
[TBL] [Abstract][Full Text] [Related]
6. Intravenous augmentative citalopram versus clomipramine in partial/nonresponder depressed patients: a short-term, low dose, randomized, placebo-controlled study.
Altamura AC; Dell'Osso B; Buoli M; Zanoni S; Mundo E
J Clin Psychopharmacol; 2008 Aug; 28(4):406-10. PubMed ID: 18626267
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.
Kennedy SH; Andersen HF; Lam RW
J Psychiatry Neurosci; 2006 Mar; 31(2):122-31. PubMed ID: 16575428
[TBL] [Abstract][Full Text] [Related]
8. Citalopram and viloxazine in the treatment of depression by means of slow drop infusion. A double-blind comparative trial.
Bouchard JM; Strub N; Nil R
J Affect Disord; 1997 Oct; 46(1):51-8. PubMed ID: 9387086
[TBL] [Abstract][Full Text] [Related]
9. Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate-to-severe depression.
Feighner JP; Overø K
J Clin Psychiatry; 1999 Dec; 60(12):824-30. PubMed ID: 10665628
[TBL] [Abstract][Full Text] [Related]
10. Citalopram: new indication. No advantage.
Prescrire Int; 1999 Feb; 8(39):18-9. PubMed ID: 10557570
[TBL] [Abstract][Full Text] [Related]
11. Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients.
Burke WJ; Gergel I; Bose A
J Clin Psychiatry; 2002 Apr; 63(4):331-6. PubMed ID: 12000207
[TBL] [Abstract][Full Text] [Related]
12. Citalopram therapy for depression: a review of 10 years of European experience and data from U.S. clinical trials.
Keller MB
J Clin Psychiatry; 2000 Dec; 61(12):896-908. PubMed ID: 11206593
[TBL] [Abstract][Full Text] [Related]
13. Does negative affectivity predict differential response to an SSRI versus a non-SSRI antidepressant?
Gerra ML; Marchesi C; Amat JA; Blier P; Hellerstein DJ; Stewart JW
J Clin Psychiatry; 2014 Sep; 75(9):e939-44. PubMed ID: 25295437
[TBL] [Abstract][Full Text] [Related]
14. Clinical implications of directly switching antidepressants in well-treated depressed patients with treatment-emergent sexual dysfunction: a comparison between vortioxetine and escitalopram.
Jacobsen PL; Nomikos GG; Zhong W; Cutler AJ; Affinito J; Clayton A
CNS Spectr; 2020 Feb; 25(1):50-63. PubMed ID: 31010445
[TBL] [Abstract][Full Text] [Related]
15. A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome.
Tack J; Broekaert D; Fischler B; Van Oudenhove L; Gevers AM; Janssens J
Gut; 2006 Aug; 55(8):1095-103. PubMed ID: 16401691
[TBL] [Abstract][Full Text] [Related]
16. [A new quality of the therapy of anxiety and depression--escitalopram].
Neznanov NG; Bortsov AV
Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(2):79-84. PubMed ID: 15792148
[No Abstract] [Full Text] [Related]
17. Short-term intravenous citalopram augmentation in partial/nonresponders with major depression: a randomized placebo-controlled study.
Altamura AC; Dell'Osso B; Buoli M; Bosi M; Mundo E
Int Clin Psychopharmacol; 2008 Jul; 23(4):198-202. PubMed ID: 18545057
[TBL] [Abstract][Full Text] [Related]
18. Can we really accelerate and enhance the selective serotonin reuptake inhibitor antidepressant effect? A randomized clinical trial and a meta-analysis of pindolol in nonresistant depression.
Portella MJ; de Diego-Adeliño J; Ballesteros J; Puigdemont D; Oller S; Santos B; Álvarez E; Artigas F; Pérez V
J Clin Psychiatry; 2011 Jul; 72(7):962-9. PubMed ID: 21034693
[TBL] [Abstract][Full Text] [Related]
19. [Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder].
Azorin JM; Llorca PM; Despiegel N; Verpillat P
Encephale; 2004; 30(2):158-66. PubMed ID: 15107719
[TBL] [Abstract][Full Text] [Related]
20. Acute antidepressive efficacy of lithium monotherapy, not citalopram, depends on recurrent course of depression.
Bschor T; Uhr M; Baethge C; Lewitzka U; Ising M; Erbe S; Winkelmann P; Ritter D
J Clin Psychopharmacol; 2013 Feb; 33(1):38-44. PubMed ID: 23277245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
